Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02502708 |
| Title | Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Primary Malignant Brain Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NewLink Genetics Corporation |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Children's Hospital Colorado | Aurora | Colorado | 80045 | United States | Details | |
| Arnold Palmer Hospital for Children | Orlando | Florida | 32806 | United States | Details | |
| Children's Heathcare of Atlanta | Atlanta | Georgia | 30342 | United States | Details | |
| Augusta University | Augusta | Georgia | 30912 | United States | Details | |
| Children's Hospitals and Clinics of Minnesota | Minneapolis | Minnesota | 55404 | United States | Details |